Stock RARE ULTRAGENYX PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Ultragenyx Pharmaceutical Inc.

Equities

RARE

US90400D1081

Market Closed - Nasdaq
Other stock markets
 01:30:00 22/06/2024 am IST 		5-day change 1st Jan Change
39.57 USD +4.08% Intraday chart for Ultragenyx Pharmaceutical Inc. +1.34% -17.25%
14/06 Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating MT
14/06 Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer
MT
Ultragenyx Pharmaceutical Insider Sold Shares Worth $574,644, According to a Recent SEC Filing
MT
Ultragenyx Pharmaceutical Insider Sold Shares Worth $1,436,100, According to a Recent SEC Filing
MT
Ultragenyx Pharmaceutical Insider Sold Shares Worth $1,307,201, According to a Recent SEC Filing
MT
Insider Sell: Ultragenyx Pharmaceutical
MT
Ultragenyx Pharmaceutical Names Howard Horn Chief Financial Officer
MT
Ultragenyx Pharmaceutical Inc. Appoints Howard Horn as Executive Vice President Effective October 16, 2023
CI
Insider Sell: Ultragenyx Pharmaceutical
MT
Insider Sell: Ultragenyx Pharmaceutical
MT
Ultragenyx Pharmaceutical Inc. Announces Retirement of Lars Ekman as Board of Directors
CI
Ultragenyx Pharmaceutical Inc. Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President
CI
Ultragenyx Pharmaceutical Chief Financial Officer Mardi Dier to Depart for Private Biopharma Company
MT
Ultragenyx Pharmaceutical Inc. Announces Departure of Mardi Dier, Executive Vice President
CI
Insider Sell: Ultragenyx Pharmaceutical
MT
Ultragenyx Pharmaceutical Inc. Announces William Aliski Will Not Stand for Re-Election as A Member of the Board of Directors
CI
Ultragenyx Pharmaceutical Inc. Announces the Appointment of Amrit Ray to Board of Directors
CI
Insider Sell: Ultragenyx Pharmaceutical
MT
Insider Sell: Ultragenyx Pharmaceutical
MT
Spruce Biosciences Names Javier Szwarcberg as CEO
MT
Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RARE Stock
  4. News Ultragenyx Pharmaceutical Inc.
  5. Insiders